Duoning Bio is a serum-free medium and technology developer. Based on the international animal cell culture concept and process development experience, it is committed to the development and production of new animal cell serum-free medium, and provides formula production and technical support for the biopharmaceutical industry. With supporting services, products include basal media such as S1, S2, S3, S3-CD and S4, as well as 2×103 feed and other feed media based on 2×103 feed; and provide customized services. Today, Duoning Bio submitted a prospectus to the Hong Kong Stock Exchange.
This article is reprinted from: https://www.itjuzi.com/pre-ipo?comname=%E5%A4%9A%E5%AE%81%E7%94%9F%E7%89%A9
This site is for inclusion only, and the copyright belongs to the original author.